Academic Journal
Harnessing veterinary nanomedicine: A One Health perspective.
| Τίτλος: | Harnessing veterinary nanomedicine: A One Health perspective. |
|---|---|
| Συγγραφείς: | Cillari R; Department of Biological Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Via Archirafi 32, 90123 Palermo, Italy., Mauro N; Department of Biological Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Via Archirafi 32, 90123 Palermo, Italy. Electronic address: nicolo.mauro@unipa.it. |
| Πηγή: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 Sep 10; Vol. 397, pp. 115139. Date of Electronic Publication: 2026 Jun 27. |
| Τύπος έκδοσης: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Amsterdam : Elsevier Science Publishers, 1984- |
| Ιατρικοί όροι (MeSH): | Nanomedicine*/methods , Veterinary Medicine*/methods , One Health*, Animals ; Drug Delivery Systems ; Humans |
| Περίληψη: | Nanomedicine exploits the unique physicochemical properties of nanomaterials to enable advanced diagnostic and therapeutic strategies. In veterinary medicine, nanotechnology is rapidly emerging as a transformative platform across companion animals, livestock, and exotic species, with direct implications for animal welfare, productivity, and the One Health framework. Although several reviews have addressed specific aspects of nanotechnology in animal health, the field is expanding rapidly, generating new technological developments and translational insights that remain dispersed across disciplines. Consequently, an updated integrative synthesis is needed to contextualize recent advances and define the evolving role of nanomedicine in veterinary and comparative biomedical research. Nanomedicines enhance drug delivery, vaccine efficacy, diagnostics, and nutrition by improving the bioavailability, targeting capability, and safety profiles of active compounds, while also offering innovative solutions to challenges such as antimicrobial resistance and neoplastic diseases. Importantly, veterinary nanomedicine occupies a dual role: it delivers tangible clinical benefits to animals and serves as a critical translational bridge, generating preclinical insights relevant to human health. This review provides an updated overview of the current state-of-the-art in veterinary nanomedicine, highlighting applications in diagnostics, drug and gene delivery, nanovaccines, and nutrition, alongside emerging smart nano-enabled technologies. Particular emphasis is placed on integrating advances reported across different sectors, underlining opportunities and limitations. We also critically examine safety, regulatory, and ethical considerations, analyzing species-specific toxicology, environmental fate, food-chain safety, and evolving regulatory outlines. Future perspectives are discussed, emphasizing the integration of nanotechnology with One Health-driven translational research to support the responsible and impactful advancement of veterinary nanomedicine. (Copyright © 2026. Published by Elsevier B.V.) |
| Contributed Indexing: | Keywords: Drug delivery; Nanomedicine; Nanotechnology; One Health; Veterinary precision medicine |
| Entry Date(s): | Date Created: 20260627 Date Completed: 20260826 Latest Revision: 20260910 |
| Update Code: | 20260910 |
| DOI: | 10.1016/j.jconrel.2026.115139 |
| PMID: | 42364700 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!